Werewolf Therapeutics, Inc.
HOWL
$0.63
-$0.03-4.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.75% | -17.26% | -36.13% | -74.15% | -88.70% |
| Total Depreciation and Amortization | -9.92% | -8.52% | -5.21% | -1.50% | 2.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.90% | -0.46% | 3.37% | -4.29% | 13.15% |
| Change in Net Operating Assets | -424.82% | -147.94% | -48.54% | 112.73% | 142.86% |
| Cash from Operations | -7.30% | -36.54% | -47.40% | -57.43% | -72.29% |
| Capital Expenditure | -- | 62.61% | 76.97% | 79.92% | 66.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 62.61% | 76.97% | 79.92% | 66.97% |
| Total Debt Issued | -- | -100.00% | -100.00% | -- | -25.00% |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | -74.63% | -79.50% | -90.32% | -88.36% | 28.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | -- | -- |
| Cash from Financing | -53.91% | -68.33% | -85.10% | -123.88% | -77.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.14% | -110.81% | -161.82% | -675.71% | -273.12% |